Delivery Order SPE2DR25D3301-SPE2DR26F19KH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,540.52 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,208.32 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The work will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $11,374.42 to AmerisourceBergen Drug Corp on December 11, 2025, for pharmaceutical products and medical supplies to support federal healthcare requirements. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,599.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis to the major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $83,743.39 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 7, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $14,592.57 delivery order (Contract No. 4570198891) to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.09 to AmerisourceBergen Drug Corp on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's broader pharmaceutical supply contract portfolio with the DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,441.47 to AmerisourceBergen Drug Corp on December 4, 2025, for pharmaceutical and medical supply products under the contract designation 4570169744. This firm fixed price delivery order, with an ultimate completion date of December 5, 2025, represents a child contract issued against AmerisourceBergen's larger indefinite delivery vehicle and is structured as a non-competitive set-aside award. The place of performance is...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19KHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,701.72 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of pharmaceutical products identified as 4570258900 DT 1C 2.25X4 700/RL 6RL/BX DHAPCL. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 12, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's critical role as a major pharmaceutical distributor supporting federal medical procurement needs across the Department of Defense and related healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor on this IDC, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal pharmaceutical requirements through open competition and its significant contract vehicle position underscore its status as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |